Burden of malaria in Sindh, Pakistan: A two years surveillance report

Journal of the Liaquat University of Medical and Health Sciences

Volumn 5, Issue 2, 2006, Pages 76-83

  Nizamani, M Akbar ^a   Kalar, Nawaz A ^b   Khushk, Imdad A ^c  

^a LIAQUAT UNIVERSITY OF MEDICAL AND HEALTH SCIENCES   (Pakistan)

^b Provincial Malaria Control Program

^c LUMHS Jamshoro Sindh

Author keywords

Malaria; Malaria control; Pakistan; Plasmodium falciparum; Roll back malaria; Sindh

Indexed keywords

ARTICLE; BLOOD EXAMINATION; BLOOD SAMPLING; DATA ANALYSIS; ENDEMIC DISEASE; HEALTH CARE PERSONNEL; HEALTH SURVEY; HUMAN; MALARIA; MALARIA CONTROL; PAKISTAN; PLASMODIUM FALCIPARUM;

EID: 39149113265     PISSN: 17290341     EISSN: None     Source Type: Journal    
DOI: 10.22442/jlumhs.06510092     Document Type: Article

References (15)

1. Roll Back Malaria. WHO. Malaria - a global crisis. Fact Sheet no. 1211- Geneva Switzerland, 2002.
2. Roll Back Malaria. WHO Eastern Mediterranean Region. Cairo, Egypt. 2002; Pp. 1-14.
3. National HMIS Cell. Situation of clinical malaria (fever) in Pakistan. National HMIS data 1998-2000, Islamabad. Ministry of Health, Govt. of Pakistan, 2001.
4. National Treatment Guidelines for Malaria. Directorate of Malaria Control. Ministry of Health Pakistan and WHO.2003.
5. Hozhabri S, Akhtar S, Rahbar MH, Luby SP. Prevalence of plasmodium positivity among the children treated for malaria, Jhangara, Sindh. J Pak Med Assoc. 2000; 5: 401-5.
6. Model Chapter for Textbooks - Integrated Management of Childhood Illnesses. Geneva: World Health Organization - Child and Adolescent Health; 2001.
7. Prybylski D, Khaliq A, Fox E, Sarwari AR, Strickland GT. Parasite density and malaria morbidity in the Pakistani Punjab. Am J Trop Med Hyg. 1999;61:791-801.
8. Hashim MJ . Primary Care in Pakistan. 2003; Pp. 1-10.
9. Nizamani MA and Memon MHA. Cerebral malaria in children: a study of 50 cases. Pak Pediatr J. 1995;19:1-17.
10. Rab MA, Freeman TW, Durrani N, de Poerck D, Rowland MW. Resistance of Plasmodium falciparum malaria to chloroquine is widespread in eastern Afghanistan. Ann Trop Med Parasitol. 2001;95:41-6.
11. Jambou R, Legrand E, Niang M, Khim N, Lim P, Volney B, et al. Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet. 2005;366:1960-3.
12. Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, White N; International Artemisinin Study Group. Artesunate combinations for treatment of malaria:meta-analysis. Lancet. 2004; 363: 9-17.
13. Durrani AB, Durrani IU, Abbas N, Jabeen M. Epidemiology of cerebral malaria and its mortality. J Pak Med Assoc. 1997; 47;213-5.
14. Hafiz R, Munir MA. A time for serious consideration towards the irrational use of antimalarial drugs in Pakistan. Pak J Med Res. 1995;34:134-5.
15. WHO Report on malaria surveillance. Malaria Control Program Pakistan. Available at: www.emro.who.int/rbm/Pak.htm. Accessed and cited in June 2006.